top of page



The Valhalla Fund's mission is to provide hope and support to individuals and families affected by Pulmonary Fibrosis while promoting awareness and advancing research toward finding a cure. Through compassionate care, education, and advocacy, we strive to improve the quality of life for those affected by this disease and work towards a future where Pulmonary Fibrosis is no longer a threat.

What is IPF?

Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive lung disease that affects approximately 132,000 people in the United States alone. IPF is characterized by the formation of scar tissue (fibrosis) in the lungs, which leads to a decline in lung function over time. This fibrosis can cause the lungs to become stiff and less able to transfer oxygen to the bloodstream, leading to shortness of breath, persistent dry cough, and fatigue. IPF is a serious condition that can significantly reduce a person's quality of life and ultimately be life-threatening.

The cause of IPF is unknown, hence the term "idiopathic." Although there are several theories about what might cause IPF, including genetic predisposition, environmental exposure to toxins, and viral infections, none have been conclusively proven. IPF primarily affects older adults, with most patients being diagnosed in their mid-60s or older. The disease progresses slowly, and in some cases, it may take several years for symptoms to become noticeable.

There is currently no cure for IPF, but treatments are available to manage symptoms and slow the progression of the disease. Oxygen therapy can help alleviate shortness of breath, and pulmonary rehabilitation can help improve lung function and overall quality of life. Medications such as pirfenidone and nintedanib have been shown to slow the progression of IPF, although they are not a cure. In some cases, lung transplantation may be recommended for patients with IPF who have significant lung damage and are not responding to other treatments.

It is important for individuals with IPF to receive a prompt and accurate diagnosis, as well as ongoing care from a team of healthcare professionals, including a pulmonologist, respiratory therapist, and physical therapist. Support from friends and family, as well as participation in support groups, can also be incredibly beneficial for individuals with IPF.


IPF is a serious and progressive lung disease that affects thousands of people worldwide. Although there is no cure, treatments are available to manage symptoms and slow the progression of the disease. It is important for individuals with IPF to receive a prompt and accurate diagnosis, as well as ongoing care and support from healthcare professionals and loved ones.

Hero's Journey

In Valhalla, where heroes reside, With shields and spears, the walls are lined. A place of glory, beyond compare, Where warriors feast, without a care.

But what of those who cannot breathe, With lungs that ache, and hearts that grieve. Whose battle is not with sword and shield, But with a disease that won't yield.

In Asgard's halls, they cannot be, For their lungs have failed, and they cannot see. The final battle, and its reward, For they cannot fight, with their chest unstored.

But they still dream of Valhalla's light, And pray for a cure, with all their might. For their struggle is not just in life, But for a chance to reach Valhalla's strife.

So let us honor those who fight, Against lung disease, day and night. For even though they cannot be, In Valhalla's halls, they still are free.

Iceland with a remote road and beautiful sky

Project Sponsors

This is a group of amazing supporters who have given time, money, and expertise for us to achieve great things for humanity. 

66°North sponsor
Go-Car-Rental sponsor
Honda Logo
Armstrong Foundation sponsor
Iceland Air Logo
Haworth sponsor

Charity Information

The Valhalla Fund is a 501(c)(3) tax-exempt nonprofit organization with a mission to serve as a trusted resource to raise awareness, provide education, and fund research.


EIN: 92-1700871

bottom of page